Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 7, 2008, Pages 685-693

  Mbonye, A K ^a   Hansen, K S ^b   Bygbjerg, I C ^c   Magnussen, P ^d  

^a MINISTRY OF HEALTH   (Uganda)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cost effectiveness; Health systems; Malaria; Pregnancy; Sulfadoxine pyrimethamine; Uganda

Indexed keywords

FANSIDAR;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INTERMITTENT THERAPY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CENTER; HUMAN; INTERMETHOD COMPARISON; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; NONHUMAN; PARASITEMIA; PATIENT COMPLIANCE; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; RECOMMENDED DRUG DOSE; UGANDA;

ADOLESCENT; ANEMIA; ANIMALS; ANTIMALARIALS; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT, NEWBORN; MALARIA; MATERNAL-CHILD HEALTH CENTERS; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; PRENATAL CARE; PYRIMETHAMINE; RISK FACTORS; SULFADOXINE; UGANDA;

EID: 44749083938     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.04.016     Document Type: Article

References (39)

1. Anand S., and Hanson K. Disability-adjusted life years: a critical review. J. Health Econ. 16 (1997) 685-702
2. Attanayake N., Fox-Rushby J., and Mills A. Household costs of malaria morbidity: a study in Matale district Sri Lanka. Trop. Med. Int. Health 5 (2000) 595-606
3. Bakyaita N., Dorsey G., Yeka A., Banek K., Staedke S.G., Kamya M., Talisuna A., Kironde F., Nsobya S., Killian A., Reinglod A., Rosenthal P., and Wabwire-Mangen F. Sulphadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomised, multi-site trial to guide national policy in Uganda. Am. J. Trop. Med. Hyg. 72 (2005) 573-580
4. Brabin B.J. An analysis of malaria in pregnancy in Africa. Bull. World Health Organ. 61 (1983) 1005-1016
5. Brabin, B.J., 1991. The risks and severity of malaria in pregnant women. Applied Field Research in Malaria Report. World Health Organization, Geneva.
6. Breman J.G., Mills A., Snow R.W., Mulligan J., Lengeler C., Mendis K., Sharp B., Morel C., Marchesini P., White N.J., Steketee R.W., and Doumbo O.K. Conquering malaria. In: Jamison D.T., Breman J.G., Measham A.R., Alleyne G., Claeson M., Evans D.B., Jha P., Mills A., and Musgrove P. (Eds). Disease Control Priorities in Developing Countries (2006), World Bank/Oxford University Press, Washington 413-431
7. Conteh L., and Walker D. Cost and unit cost calculations using step-down accounting. Health Policy Plan. 19 (2004) 127-135
8. Desai M., ter Kuile F.O., Nosten F., McGready R., Asamoa K., Brabin B., and Newman R. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 7 (2007) 93-104
9. Dorsey G., Dokomajilar C., Kiggundu M., Staedke S.G., Kamya M.R., and Rosenthal P.J. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. Am. J. Trop. Med. Hyg. 71 (2004) 758-763
10. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B., and Stoddart G.L. Methods for the Economic Evaluation of Health Care Programmes (2005), Oxford University Press, Oxford
11. Goodman C.A., Coleman P.G., and Mills A.J. Cost-effectiveness of malaria control in Africa. Lancet 354 (1999) 378-385
12. Goodman, C., Coleman, P., Mills A., 2000. Economic analysis of malaria control in sub-Saharan Africa. Global Forum for Health Research, World Health Organization, Geneva.
13. Goodman C.A., Coleman P.G., and Mills A.J. Cost-effectiveness of antenatal malaria prevention in sub-Saharan Africa, malaria control in Africa. Am. J. Trop. Med. Hyg. 64 (2001) 45-56
14. Greenwood B., Alonso P., ter Kuile F.O., Hill J., and Steketee R.W. Malaria in pregnancy: priorities for research. Lancet Infect. Dis. 7 (2007) 169-174
15. Heggenhougen, H.K., Hackenthal, V., Vivek, P., 2003. Bed nets usage and its acceptance at the local level, in: The behavioural and social aspects of malaria control: an introduction and annotated biography. Special Program for Research and Training in Tropical Diseases, pp. 97-106. http://www.who.int/tdr/publications/publications/seb-malaria.htm [accessed 2 October 2007].
16. Helitzer-Allen D.L., Wirima J.J., Macheso A.P., and Kendall C. Testing strategies to increase use of chloroquine chemoprophylaxisis during pregnancy in Malawi. Acta Trop. 58 (1994) 255-266
17. Lyttkens C.H. Time to disable DALYs? On the use of disability-adjusted life years in health policy. Eur. J. Health Econ. 4 (2003) 195-202
18. Mbonye A.K., Neema S., and Magnussen P. Treatment seeking practices for malaria in pregnancy among rural women in Mukono District, Uganda. J. Biosoc. Sci. 38 (2006) 221-237
19. Mbonye A.K., Bygbjerg I., and Magnussen P. Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance in Uganda. Trop. Med. Int. Health 12 (2007) 519-531
20. Mbonye A.K., Bygbjerg I., and Magnussen P. Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda. Int. J. Infect. Dis. 12 (2008) 22-29
21. McGregor I.A., Wilson M.E., and Bilewicz W.Z. Malaria infection of the placenta in the Gambia, West Africa, its incidence and relationship to birth weight and placenta weight. Trans. R. Soc. Trop. Med. Hyg. 93 (1983) 529-534
22. Menendez C. Priority areas for current research in malaria during pregnancy. Ann. Trop. Med. Parasitol. 1 (1999) 571-574
23. Mills A. The consequences of malaria for households: a case study in Nepal. Health Policy 29 (1994) 209-227
24. Ministry of Health Uganda, 2001. The Malaria in Pregnancy Control Policy. Ministry of Health, Kampala, Uganda.
25. Ministry of Health/WHO, 2005. Economic Burden of Malaria in Uganda. Ministry of Health, Kampala, Uganda.
26. Murray C.J.L. Rethinking DALYs. In: Murray C.J.L., and Lopez A.D. (Eds). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 (1996), Harvard University Press, Cambridge, MA
27. Ndyomugyenyi R., Neema S., and Magnussen P. The use of formal and informal services for antenatal care and malaria treatment in rural Uganda. Health Policy Plan. 13 (1999) 94-104
28. Nosten F., Rogerson S.J., Beeson J.G., McGready R., Mutabingwa T.K., and Brabin B. Malaria in pregnancy and the endemicity spectrum: what can we learn?. Trends Parasitol. 20 (2004) 425-432
29. RBM (Roll Back Malaria), 2000. Scaling up insecticide-treated netting (ITN) programs in Africa: A strategic framework for coordinated national action. RBM/WHO, Geneva.
30. Shulman C.E., Marshall T., Dorman E.K., Bulmer J.N., Cutts E., Peshu N., and Marsh K. Malaria in pregnancy: adverse effects on haemoglobin levels and birth weight in primigravidae and multigravidae. Trop. Med. Int. Health 6 (2001) 770-778
31. Schultz L.J., Steketee R.W., Chitsulo L., and Wirima J.J. Antimalarial drugs during pregnancy: a cost effectiveness analysis. Bull. World Health Organ. 73 (1995) 207-214
32. Schultz L.J., Steketee R.W., Macheso A., Kazembe P., Chitsulo L., and Wirima J.J. The efficacy of antimalaria regimens containing sulphadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum among pregnant women in Malawi. Am. J. Trop. Med. Hyg. 51 (1996) 515-522
33. Talisuna A.O., Langi P., Bakyayita N., Egwang T., Mutabingwa T.K., Walkins W., Van Marck E., and D'Alessandro U. Intensity of malaria transmission, antimalaria-drug use and resistance in Uganda: what is the relationship between these factors?. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 310-317
34. Uganda Bureau of Statistics, 2006. The Uganda Demographic and Health Survey - Preliminary report. Uganda Bureau of Statistics, Kampala, Uganda.
35. Walker D., and Fox-Rushby J. Economic evaluation of parasitic diseases: a critique of the internal and external validity of published studies. Trop. Med. Int. Health 5 (2000) 237-249
36. Walker D., and Kumaranayake L. Allowing for differential timing in cost analyses: discounting and annualization. Health Policy Plan. 17 (2002) 112-118
37. WHO, 1993. Implementation of the global malaria control strategy. World Health Organization, Geneva, Technical Report Series No. 839.
38. Wolfe E.B., Parise M.E., Haddix A.C., Nahlen B.L., Ayisi J.G., Misore A., and Steketee R.W. Cost-effectiveness of sulphadoxine-pyrimethamine for the prevention of malaria-associated low birth weight. Am. J. Trop. Med. Hyg. 64 (2001) 178-186
39. World Bank, 1993. Investing in Health: World Development Report 1993. World Bank/Oxford University Press, New York.